| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Psychiatric Bulletin | Advances in Psychiatric Treatment | All RCPsych Journals |
|
|
|
||||||||||
|
||||||||||||
Department of Clinical Research, Crichton Royal Hospital, Dumfries DG1 4TG, UK.
Correspondence: Tel: +44 (0) 1387 244000; fax: 44 (0) 1387 257735; e-mail: rgmccreadie_crh{at}compuserve.com
Declaration of interest None. The study was funded by the Chief Scientist Office, Scottish Executive, Edinburgh.
Background Specialised services should be developed to help people with schizophrenia and associated substance misuse. The extent of the problem therefore needs to be known.
Aims To determine the use of drugs, alcohol and tobacco by people with schizophrenia drawn from rural, suburban and urban settings, and to compare use by general population control subjects.
Method People with schizophrenia (n=316) and general population controls of similar gender distribution, age and postcode area of residence (n=250) were identified in rural, urban and suburban areas of Scotland. Use of drugs and alcohol was assessed by the Schedules for Clinical Assessment in Neuropsychiatry, and use of tobacco by a questionnaire.
Results More patients than controls reported problem use of drugs in the past year (22 (7%) v. 5 (2%)) and at some time before then (50 (20%) v. 15 (6%)) and problem use of alcohol in the past year (42 (17%) v. 25 (10%)) but not at some time previously (99 (40%) v. 84 (34%)). More patients were current smokers (162 (65%) v. 99 (40%)).
Conclusions Problem use of drugs and alcohol by people with schizophrenia is greater than in the general population, but absolute numbers are small. Tobacco use is the greatest problem.
This article has been cited by other articles:
|
|
 |
|
  L. Borras, S. Mohr, P.-Y. Brandt, C. Gillieron, A. Eytan, and P. Huguelet Influence of Spirituality and Religiousness On Smoking Among Patients With Schizophrenia or Schizo-Affective Disorder in Switzerland International Journal of Social Psychiatry, November 1, 2008; 54(6): 539 - 549. [Abstract] [PDF]
|
|
|
|
 |
|
 J. Hippisley-Cox, Y. Vinogradova, C. Coupland, and C. Parker Risk of Malignancy in Patients With Schizophrenia or Bipolar Disorder: Nested Case-Control Study Arch Gen Psychiatry, December 1, 2007; 64(12): 1368 - 1376. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Kooyman, K. Dean, S. Harvey, and E. Walsh Outcomes of public concern in schizophrenia The British Journal of Psychiatry, August 1, 2007; 191(50): s29 - s36. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. H. BARNETT, U. WERNERS, S. M. SECHER, K. E. HILL, R. BRAZIL, K. MASSON, D. E. PERNET, J. B. KIRKBRIDE, G. K. MURRAY, ED. T. BULLMORE, et al. Substance use in a population-based clinic sample of people with first-episode psychosis The British Journal of Psychiatry, June 1, 2007; 190(6): 515 - 520. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. S. Swartz, H. R. Wagner, J. W. Swanson, T. S. Stroup, J. P. McEvoy, M. McGee, D. D. Miller, F. Reimherr, A. Khan, J. M. Canive, et al. Substance Use and Psychosocial Functioning in Schizophrenia Among New Enrollees in the NIMH CATIE Study Psychiatr Serv, August 1, 2006; 57(8): 1110 - 1116. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Shah and L. Howard Screening for smoking and substance misuse in pregnant women with mental illness Psychiatr. Bull., August 1, 2006; 30(8): 294 - 297. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. GREEN, R. YOUNG, and D. KAVANAGH Cannabis use and misuse prevalence among people with psychosis The British Journal of Psychiatry, October 1, 2005; 187(4): 306 - 313. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. C. Aguilar, M. Gurpegui, F. J. Diaz, and J. De Leon Nicotine dependence and symptoms in schizophrenia: Naturalistic study of complex interactions The British Journal of Psychiatry, March 1, 2005; 186(3): 215 - 221. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Kagan, R. Kigli-Shemesh, N. Tabak, M. Z Abramowitz, and J. Margolin Patient Rights and Law: tobacco smoking in psychiatric wards and the Israeli Prevention of Smoking Act Nursing Ethics, September 1, 2004; 11(5): 472 - 478. [Abstract] [PDF]
|
|
|
|
 |
|
 M. T. Isaac and M. B. Isaac Consensus Development Conference on Antipsychotic Drugs and Obesity and Diabetes: Response to consensus statement Diabetes Care, August 1, 2004; 27(8): 2088 - 2088. [Full Text] [PDF]
|
|
|
|
|
|
L. Arseneault, M. Cannon, J. Witton, and R. M. Murray Causal association between cannabis and psychosis: examination of the evidence The British Journal of Psychiatry, February 2, 2004; 184(2): 110 - 117. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. PHILLIPS and S. JOHNSON Drug and alcohol misuse among in-patients with psychotic illnesses in three inner-London psychiatric units Psychiatr. Bull., June 1, 2003; 27(6): 217 - 220. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Bates, J. Rutherford, and R. G. McCreadie Problem substance use and schizophrenia * Author's reply The British Journal of Psychiatry, May 1, 2003; 182(5): 455 - 455. [Full Text] [PDF]
|
|
|
|
|
|
K. A. L. A. Kuruppuarachchi and S. S. Williams Betel use and schizophrenia The British Journal of Psychiatry, May 1, 2003; 182 (5): 455 - 455. [Full Text] [PDF]
|
|
|
|
|
|
R. CANTWELL Substance use and schizophrenia: effects on symptoms, social functioning and service use The British Journal of Psychiatry, April 1, 2003; 182(4): 324 - 329. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. MACDONALD, J. HALLIDAY, T. MacEWAN, V. SHARKEY, S. FARRINGTON, S. WALL, and R. G. McCREADIE Nithsdale Schizophrenia Surveys 24: sexual dysfunction: Case--control study The British Journal of Psychiatry, January 2, 2003; 182(1): 50 - 56. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Psychiatric Bulletin | Advances in Psychiatric Treatment | All RCPsych Journals |
